Navigation Links
Varian, Inc. Announces First Quarter 2009 Preliminary Results
Date:1/16/2009

PALO ALTO, Calif., Jan. 16 /PRNewswire-FirstCall/ -- Varian, Inc. (NasdaqGS: VARI) today announced preliminary results for the first quarter of its fiscal year 2009, which ended January 2, 2009.

First quarter sales should be between $205 million and $210 million. Non- GAAP (adjusted) diluted earnings per share should be between $0.50 and $0.54 including share-based compensation expense of approximately $0.05. On a GAAP basis, diluted earnings per share should be between $0.41 and $0.45. Adjusted operating margins should be between 11.2% and 11.4% in the quarter, while GAAP operating margins should be between 9.4% and 9.6%. Operating cash flow should be between $15 million and $20 million for the quarter.

For a complete reconciliation of non-GAAP (adjusted) financial information used in this press release to the most directly comparable GAAP financial information, please refer to the attached Reconciliations of GAAP to Adjusted Results, Preliminary.

Sales were below expectations in the first quarter primarily due to lower revenues from research products (in particular NMR and imaging systems). Despite order weakness late in the quarter, in particular for certain vacuum and analytical products, total company orders exceeded sales for the quarter. Adjusted operating margins held up well, even on lower revenues, due to the positive impact of efficiency improvements implemented in recent years and favorable foreign currency movements. In addition, operating cash flow was solid during the quarter.

"With respect to our research products sales, we have said many times that the timing of revenues on these products is impacted by factors such as laboratory readiness and access to customer sites, duration of installations and availability of key components and installation personnel," said Garry W. Rogerson, President and Chief Executive Officer. "Although we entered the first quart
'/>"/>

SOURCE Varian, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related biology technology :

1. Varian, Inc. Announces Cost Reduction Plan
2. Varian, Inc. Announces Online Experience
3. Varian, Inc. CEO to Speak at the Nasdaq OMX 22nd Investor Program
4. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
5. New Flexible Vacuum Controller from Varian, Inc. is Expandable and Easy to Use
6. Varian, Inc. Board of Directors Makes Officer Changes
7. Varian, Inc. to Present at Thomas Weisel Partners 2008 Healthcare Conference
8. New Dual Wavelength X-ray Diffractometer From Oxford Diffraction, Now a Part of Varian, Inc., Allows Increased Throughput for Challenging Single Crystal Analyses
9. New Turbomolecular Pumping System From Varian, Inc. Delivers Portable, Dry, Ultra-high Vacuum.
10. Varian, Inc. Reports Third Quarter 2008 Results
11. James T. Glover Appointed to Board of Directors of Varian, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... 2015 Research and Markets ( ... PharmaBiotech,s new report "Biomarkers - Technologies, Markets ... This report follows the broad definition of ... objectively measured and evaluated as an indicator of ... pharmacological responses to a therapeutic intervention. Tests based ...
(Date:3/4/2015)... March 04, 2015 Proove ... Personalized Medicine, is excited to announce the launch ... to Optimize the Management of Pain”. , The ... Medscape.com for the next year. The focus of ... to recognize inadequate pain treatments, integrate appropriate pain ...
(Date:3/4/2015)... 2015 Follow us on LinkedIn ... the fastest growing technologies in the life sciences industry. ... is driving growth in nucleic acid detection technologies like ... gene expressions will continue to benefit the qPCR and ... ranging from pharma, biotech, food & beverage to animal ...
(Date:3/3/2015)... March 3, 2015 /PRNewswire/ - Aptose Biosciences Inc. (NASDAQ: ... and molecular diagnostics that target the underlying mechanisms of ... seventh-month period ended December 31, 2014. Effective ... end from May 31 to December 31. As a ... today are for the quarter and the seven months ...
Breaking Biology Technology:Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 2Global Biomarkers Report 2014-2024 - Technologies, Markets and Companies 3Proove Biosciences Launches CME Accredited Program with Medscape 2Proove Biosciences Launches CME Accredited Program with Medscape 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 2Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 3Focus on Quantifying Nucleic Acid Molecules Spurs Growth in the qPCR & dPCR Instrumentation Market, According to a New Report by Global Industry Analysts, Inc. 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 2Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 3Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 4Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 5Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 6Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 7Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 8Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 9Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 10Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 11Aptose Biosciences reports results for the quarter and seven months ended December 31, 2014 12
... Quarter 2008 Corporate Highlights:, - European marketing application under review for NGX-4010 in ... ... second half of 2008 - IND submitted and opened for NGX-1998 liquid capsaicin ... Phase 1 clinical trial of NGX-1998 initiated, - Journal Neurology published positive Phase 3 ...
... Aug. 13 Mentice, Inc. and MATC have,forged ... to work on multiple,and mutually beneficial projects to ... and teaching institutions throughout North America., Mentice,s ... technician and/or attending physician to gain exposure to ...
... 13 According to new research from,BioInformatics, LLC ... consulting firm serving the life science industry -- ... to find new ways to,demonstrate customer value. As ... (OEM), in-house and a,combination of all three, vendors ...
Cached Biology Technology:NeurogesX Reports Second Quarter 2008 Results 2NeurogesX Reports Second Quarter 2008 Results 3NeurogesX Reports Second Quarter 2008 Results 4NeurogesX Reports Second Quarter 2008 Results 5NeurogesX Reports Second Quarter 2008 Results 6NeurogesX Reports Second Quarter 2008 Results 7NeurogesX Reports Second Quarter 2008 Results 8NeurogesX Reports Second Quarter 2008 Results 9Mentice, Inc. and the Milwaukee Area Technical College (MATC) Announce Their Partnership in the Area of Procedural Medical Simulation 2BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts 2BioInformatics, LLC Offers Solutions for Optimizing Service and/or Maintenance Contracts 3
(Date:2/5/2015)... Feb. 5, 2015  Marken is starting its 35 ... has launched a new marketing campaign to solidify its ... The new campaign focuses on First as ... shipments. The first headline in the series, ... priorities with its client,s priorities. Marken recognizes the need ...
(Date:2/5/2015)... IRVINE, Calif. , Jan. 27, 2015 ... trusted provider of globally deployed, innovative test ... today announced the delivery of its ... Martin Space Systems Company (LMSSC). GENASYS is ... the demands of mission-critical applications that require ...
(Date:2/5/2015)... DUBLIN , Jan. 28, 2015 Research ... announced the addition of the "Global Biometrics ... Use, Regions and Countries " report to their ... market, Asia-Pacific is anticipated ... by 2015, owing to increasing government spending towards ...
Breaking Biology News(10 mins):Marken Launches New Patient-Centric Campaign 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 2Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 3Marvin Test Solutions' GENASYS Platform Advances Mission-Critical Aerospace Production Test 4Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 2Global Biometrics Market (2014-2020): Market Forecast By Technologies, Applications, End Use, Regions and Countries 3
... University of Missouri scientist Ray Semlitsch studies creatures most ... at night and thrive in the shallow, cool, wet ... A collaborative study, with MU graduate student Bill Peterman, ... biomass (total mass of an organism in an area) ...
... COLD SPRING HARBOR, N.Y. Despite the fact ... birth defect in the United States, pediatric cardiology receives ... a new photodocumentary volume entitled My Heart vs. ... children with CHD. Through striking black-and-white photographs and ...
... in Spanish . , ANN ARBOR, Mich.---University ... Institute on Aging have produced the largest and most ... trove offering new insights into early migrations out of ... build ever-larger telescopes to peer deeper into space, population ...
Cached Biology News:Salamanders, headwater streams critical in food chain 2New book gives a human face to children with congenital heart disease 2U-M researchers release most detailed global study of genetic variation 2U-M researchers release most detailed global study of genetic variation 3
RECOMBINANT EQUINE IL-4 Product Type: Recombinant Protein...
RECOMBINANT EQUINE TNF ALPHA Product Type: Recombinant Protein...
Request Info...
Request Info...
Biology Products: